{"data":[{"accessionNo":"0001477932-26-006433","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0000318306","issuerName":"ABEONA THERAPEUTICS INC.","ticker":"ABEO","cusip":"00289Y206","securityClass":"Common Stock, $0.01 par value","eventDate":"2026-10-15","reportingPerson":"James Russell","reportingCik":null,"personType":"IN","sharesOwned":3479963,"percentOfClass":6.1,"filedAt":"2026-10-23","canonicalUrl":"https://xoomar.com/markets/stocks/abeo"},{"accessionNo":"0001477932-26-006433","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0000318306","issuerName":"ABEONA THERAPEUTICS INC.","ticker":"ABEO","cusip":"00289Y206","securityClass":"Common Stock, $0.01 par value","eventDate":"2026-10-15","reportingPerson":"James Russell Revocable Trust","reportingCik":"0002089521","personType":"OO","sharesOwned":3479963,"percentOfClass":6.1,"filedAt":"2026-10-23","canonicalUrl":"https://xoomar.com/markets/stocks/abeo"},{"accessionNo":"0000919574-26-005538","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0000318306","issuerName":"Abeona Therapeutics Inc.","ticker":"ABEO","cusip":"00289Y206","securityClass":"Common Stock, $0.01 par value","eventDate":"2026-06-30","reportingPerson":"Montanova Capital, LLC","reportingCik":null,"personType":"IA,OO","sharesOwned":500000,"percentOfClass":0.9,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/abeo"},{"accessionNo":"0000919574-26-005538","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0000318306","issuerName":"Abeona Therapeutics Inc.","ticker":"ABEO","cusip":"00289Y206","securityClass":"Common Stock, $0.01 par value","eventDate":"2026-06-30","reportingPerson":"Aaron Cowen","reportingCik":null,"personType":"HC,IN","sharesOwned":500000,"percentOfClass":0.9,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/abeo"},{"accessionNo":"0001104659-26-062715","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0000318306","issuerName":"ABEONA THERAPEUTICS INC.","ticker":"ABEO","cusip":"00289Y206","securityClass":"Common Stock, $0.01 par value","eventDate":"2026-03-31","reportingPerson":"Daniel Mack","reportingCik":null,"personType":"HC","sharesOwned":5775350,"percentOfClass":9.99,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/abeo"},{"accessionNo":"0001104659-26-062715","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0000318306","issuerName":"ABEONA THERAPEUTICS INC.","ticker":"ABEO","cusip":"00289Y206","securityClass":"Common Stock, $0.01 par value","eventDate":"2026-03-31","reportingPerson":"Wilmot B. Harkey","reportingCik":null,"personType":"HC","sharesOwned":5775350,"percentOfClass":9.99,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/abeo"},{"accessionNo":"0001104659-26-062715","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0000318306","issuerName":"ABEONA THERAPEUTICS INC.","ticker":"ABEO","cusip":"00289Y206","securityClass":"Common Stock, $0.01 par value","eventDate":"2026-03-31","reportingPerson":"Nantahala Capital Management, LLC","reportingCik":null,"personType":"IA","sharesOwned":5775350,"percentOfClass":9.99,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/abeo"},{"accessionNo":"0001104659-26-062655","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000318306","issuerName":"ABEONA THERAPEUTICS INC.","ticker":"ABEO","cusip":"00289Y206","securityClass":"Common Stock, $0.01 par value","eventDate":"2026-03-31","reportingPerson":"NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP","reportingCik":null,"personType":"PN","sharesOwned":3333757,"percentOfClass":5.82,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/abeo"},{"accessionNo":"0001493152-26-019340","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000318306","issuerName":"ABEONA THERAPEUTICS INC.","ticker":"ABEO","cusip":"00289Y206","securityClass":"Common Stock, $0.01 par value","eventDate":"2026-03-31","reportingPerson":"AIGH Capital Management LLC","reportingCik":null,"personType":"IA,OO","sharesOwned":3100000,"percentOfClass":5.4,"filedAt":"2026-04-28","canonicalUrl":"https://xoomar.com/markets/stocks/abeo"},{"accessionNo":"0001493152-26-019340","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000318306","issuerName":"ABEONA THERAPEUTICS INC.","ticker":"ABEO","cusip":"00289Y206","securityClass":"Common Stock, $0.01 par value","eventDate":"2026-03-31","reportingPerson":"Orin Hirschman","reportingCik":null,"personType":"HC,IN","sharesOwned":3100000,"percentOfClass":5.4,"filedAt":"2026-04-28","canonicalUrl":"https://xoomar.com/markets/stocks/abeo"},{"accessionNo":"0002073679-26-000044","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000318306","issuerName":"ABEONA THERAPEUTICS INC.","ticker":"ABEO","cusip":"00289Y206","securityClass":"Common Stock, par value $0.01","eventDate":"2026-03-27","reportingPerson":"Funicular Funds, LP","reportingCik":null,"personType":"PN","sharesOwned":3007329,"percentOfClass":5.3,"filedAt":"2026-04-06","canonicalUrl":"https://xoomar.com/markets/stocks/abeo"},{"accessionNo":"0002073679-26-000044","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000318306","issuerName":"ABEONA THERAPEUTICS INC.","ticker":"ABEO","cusip":"00289Y206","securityClass":"Common Stock, par value $0.01","eventDate":"2026-03-27","reportingPerson":"Cable Car Capital, LP","reportingCik":null,"personType":"PN,IA","sharesOwned":3007329,"percentOfClass":5.3,"filedAt":"2026-04-06","canonicalUrl":"https://xoomar.com/markets/stocks/abeo"},{"accessionNo":"0002073679-26-000044","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000318306","issuerName":"ABEONA THERAPEUTICS INC.","ticker":"ABEO","cusip":"00289Y206","securityClass":"Common Stock, par value $0.01","eventDate":"2026-03-27","reportingPerson":"Ma-Weaver Jacob","reportingCik":null,"personType":"IN","sharesOwned":3007329,"percentOfClass":5.3,"filedAt":"2026-04-06","canonicalUrl":"https://xoomar.com/markets/stocks/abeo"},{"accessionNo":"0001099910-26-000139","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000318306","issuerName":"ABEONA THERAPEUTICS INC.","ticker":"ABEO","cusip":"00289Y206","securityClass":"Common Stock, $0.01 par value","eventDate":"2026-03-26","reportingPerson":"Daniel Kaufman","reportingCik":null,"personType":"IN","sharesOwned":2943629,"percentOfClass":5.16,"filedAt":"2026-03-27","canonicalUrl":"https://xoomar.com/markets/stocks/abeo"},{"accessionNo":"0000102909-26-000362","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000318306","issuerName":"Abeona Therapeutics Inc","ticker":"ABEO","cusip":"00289Y206","securityClass":"Common Stock","eventDate":"2026-03-13","reportingPerson":"The Vanguard Group","reportingCik":null,"personType":"IA","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-03-26","canonicalUrl":"https://xoomar.com/markets/stocks/abeo"},{"accessionNo":"0000902664-26-000906","formType":"SCHEDULE 13G/A","amendmentNo":11,"issuerCik":"0000318306","issuerName":"ABEONA THERAPEUTICS INC.","ticker":"ABEO","cusip":null,"securityClass":"Common Stock, par value $0.01 per share","eventDate":"2025-12-31","reportingPerson":"Adage Capital Management, L.P.","reportingCik":null,"personType":"IA,PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-02-12","canonicalUrl":"https://xoomar.com/markets/stocks/abeo"},{"accessionNo":"0000902664-26-000906","formType":"SCHEDULE 13G/A","amendmentNo":11,"issuerCik":"0000318306","issuerName":"ABEONA THERAPEUTICS INC.","ticker":"ABEO","cusip":null,"securityClass":"Common Stock, par value $0.01 per share","eventDate":"2025-12-31","reportingPerson":"Robert Atchinson","reportingCik":null,"personType":"HC,IN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-02-12","canonicalUrl":"https://xoomar.com/markets/stocks/abeo"},{"accessionNo":"0000902664-26-000906","formType":"SCHEDULE 13G/A","amendmentNo":11,"issuerCik":"0000318306","issuerName":"ABEONA THERAPEUTICS INC.","ticker":"ABEO","cusip":null,"securityClass":"Common Stock, par value $0.01 per share","eventDate":"2025-12-31","reportingPerson":"Phillip Gross","reportingCik":null,"personType":"HC,IN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-02-12","canonicalUrl":"https://xoomar.com/markets/stocks/abeo"},{"accessionNo":"0000902664-25-004895","formType":"SCHEDULE 13G/A","amendmentNo":10,"issuerCik":"0000318306","issuerName":"Abeona Therapeutics Inc.","ticker":"ABEO","cusip":null,"securityClass":"Common Stock, par value $0.01 per share","eventDate":"2025-09-30","reportingPerson":"Phillip Gross","reportingCik":null,"personType":"HC,IN","sharesOwned":5352996,"percentOfClass":9.99,"filedAt":"2025-11-13","canonicalUrl":"https://xoomar.com/markets/stocks/abeo"},{"accessionNo":"0000902664-25-004895","formType":"SCHEDULE 13G/A","amendmentNo":10,"issuerCik":"0000318306","issuerName":"Abeona Therapeutics Inc.","ticker":"ABEO","cusip":null,"securityClass":"Common Stock, par value $0.01 per share","eventDate":"2025-09-30","reportingPerson":"Adage Capital Management, L.P.","reportingCik":null,"personType":"IA,PN","sharesOwned":5352996,"percentOfClass":9.99,"filedAt":"2025-11-13","canonicalUrl":"https://xoomar.com/markets/stocks/abeo"},{"accessionNo":"0000902664-25-004895","formType":"SCHEDULE 13G/A","amendmentNo":10,"issuerCik":"0000318306","issuerName":"Abeona Therapeutics Inc.","ticker":"ABEO","cusip":null,"securityClass":"Common Stock, par value $0.01 per share","eventDate":"2025-09-30","reportingPerson":"Robert Atchinson","reportingCik":null,"personType":"HC,IN","sharesOwned":5352996,"percentOfClass":9.99,"filedAt":"2025-11-13","canonicalUrl":"https://xoomar.com/markets/stocks/abeo"},{"accessionNo":"0000102909-25-000059","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000318306","issuerName":"Abeona Therapeutics Inc","ticker":"ABEO","cusip":null,"securityClass":"Common Stock","eventDate":"2025-09-30","reportingPerson":"The Vanguard Group","reportingCik":null,"personType":"IA","sharesOwned":2602901,"percentOfClass":5.07,"filedAt":"2025-10-30","canonicalUrl":"https://xoomar.com/markets/stocks/abeo"},{"accessionNo":"0001104659-25-097132","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0000318306","issuerName":"ABEONA THERAPEUTICS INC.","ticker":"ABEO","cusip":null,"securityClass":"Common Stock, $0.01 par value","eventDate":"2025-09-30","reportingPerson":"Nantahala Capital Management, LLC","reportingCik":null,"personType":"IA,HC","sharesOwned":5184662,"percentOfClass":9.99,"filedAt":"2025-10-06","canonicalUrl":"https://xoomar.com/markets/stocks/abeo"},{"accessionNo":"0001104659-25-097132","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0000318306","issuerName":"ABEONA THERAPEUTICS INC.","ticker":"ABEO","cusip":null,"securityClass":"Common Stock, $0.01 par value","eventDate":"2025-09-30","reportingPerson":"Wilmot B. Harkey","reportingCik":null,"personType":"IN","sharesOwned":5184662,"percentOfClass":9.99,"filedAt":"2025-10-06","canonicalUrl":"https://xoomar.com/markets/stocks/abeo"},{"accessionNo":"0001104659-25-097132","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0000318306","issuerName":"ABEONA THERAPEUTICS INC.","ticker":"ABEO","cusip":null,"securityClass":"Common Stock, $0.01 par value","eventDate":"2025-09-30","reportingPerson":"Daniel Mack","reportingCik":null,"personType":"IN","sharesOwned":5184662,"percentOfClass":9.99,"filedAt":"2025-10-06","canonicalUrl":"https://xoomar.com/markets/stocks/abeo"},{"accessionNo":"0001104659-25-097130","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000318306","issuerName":"ABEONA THERAPEUTICS INC.","ticker":"ABEO","cusip":null,"securityClass":"Common Stock, $0.01 par value","eventDate":"2025-09-29","reportingPerson":"NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP","reportingCik":null,"personType":"PN","sharesOwned":2618462,"percentOfClass":5.09,"filedAt":"2025-10-06","canonicalUrl":"https://xoomar.com/markets/stocks/abeo"},{"accessionNo":"0002089521-25-000001","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000318306","issuerName":"ABEONA THERAPEUTICS INC.","ticker":"ABEO","cusip":null,"securityClass":"Class A Common Stock","eventDate":"2025-09-16","reportingPerson":"James Russell Revocable Trust","reportingCik":null,"personType":"OO","sharesOwned":2720875,"percentOfClass":5.3,"filedAt":"2025-09-30","canonicalUrl":"https://xoomar.com/markets/stocks/abeo"}],"updatedAt":"2026-11-05T13:28:07.427Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/abeo","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}